SAHA Analogues Bearing Azaheterocycles in CAP Group and Variable Methylene Chain Length: Synthesis and HDAC Inhibitory Ability
Preprint
- 22 November 2023
- preprint
- Published by MDPI AG in Preprints.org
Abstract
This review covers the last 25 years literature on analogs of suberoylanilide hydroxamic acid (SAHA, known also as Vorinostat) acting as HDAC inhibitor. In particular, the topic has been focused on the synthesis and biological activity of compounds where the phenyl group (the surface recognition moiety, CAP) of SAHA has been replaced by an azaheterocycle through a direct bond with amide nitrogen atom, and the methylene chain in the linker region is of variable length. Most of the compounds reported displayed good to excellent inhibitory activity against HDACs and in many cases showed anti-proliferative activity against human cancer cell lines.Keywords
All Related Versions
- Version 1, 2023-11-22, Preprints
- Published version: Molecules, 29 (1), 238.
This publication has 35 references indexed in Scilit:
- Synthesis of benzoxazole-based vorinostat analogs and their antiproliferative activityBioorganic Chemistry, 2021
- Chemical Control System of EpigeneticsThe Chemical Record, 2018
- Design, synthesis and biological evaluation of isoquinoline-based derivatives as novel histone deacetylase inhibitorsBioorganic & Medicinal Chemistry, 2015
- Improved antiproliferative activity of 1,3,4-thiadiazole-containing histone deacetylase (HDAC) inhibitors by introduction of the heteroaromatic surface recognition motifBioorganic & Medicinal Chemistry, 2014
- Design, synthesis and biological evaluation of 4-anilinothieno[2,3-d]pyrimidine-based hydroxamic acid derivatives as novel histone deacetylase inhibitorsBioorganic & Medicinal Chemistry, 2014
- Design, synthesis and preliminary bioactivity studies of 1,3,4-thiadiazole hydroxamic acid derivatives as novel histone deacetylase inhibitorsBioorganic & Medicinal Chemistry, 2012
- Chemistry, Biology, and QSAR Studies of Substituted Biaryl Hydroxamates and Mercaptoacetamides as HDAC Inhibitors—Nanomolar‐Potency Inhibitors of Pancreatic Cancer Cell GrowthChemMedChem, 2008
- HDAC inhibitors: Clinical update and mechanism-based potentialBiochemical Pharmacology, 2007
- Prospects: Histone deacetylase inhibitorsJournal of Cellular Biochemistry, 2005
- Differential protein acetylation induced by novel histone deacetylase inhibitorsBiochemical and Biophysical Research Communications, 2004